scyllo-inositol
Small moleculeexperimental
scyllo-Inositol, also called scyllitol, cocositol, or quercinitol, is a chemical compound with formula C6H12O6, one of the nine inositols, the stereoisomers of cyclohexane-1,2,3,4,5,6-hexol. The molecule has a ring of six carbon atoms, each bound to one hydrogen atom and one hydroxyl group (–OH); if the ring is assumed horizontal, the hydroxyls lie alternately above and below the respective hydrogens. — Wikipedia
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT00568776)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaScyllo-Inositol ↗
Also known as
- elnd005
- scyllo-inositol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01791725 | Phase 2 | Sep 1, 2013 | Elan Pharmaceuticals, Transition Therapeutics |
| NCT01766336 | Phase 2 | Jan 1, 2013 | Elan Pharmaceuticals, Transition Therapeutics |
| NCT01735630 | Phase 2 | Nov 1, 2012 | Elan Pharmaceuticals, Transition Therapeutics |
| NCT01674010 | Phase 2 | Aug 1, 2012 | Elan Pharmaceuticals, Transition Therapeutics |
| NCT00934050 | Phase 2 | Jun 1, 2009 | Transition Therapeutics |
| NCT00568776 | Phase 2 | Dec 1, 2007 | Transition Therapeutics |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Transition Therapeutics | For profit | 6 | 6 | 1 | 2007 |
| Elan Pharmaceuticals | For profit | 4 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1